Cannalean Biotechs Cannalean Biotechs Cannalean Biotechs Cannalean Biotechs
Navigation
  • Home
  • The Company
  • The Team
  • Our Partners
  • Contact Us

CBD Based Therapies:

Cannalean Biotechs Ltd. founded in 2017 and headquartered in Israel, is a company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan that will potentially benefit millions of patients suffering from dyslipidemia

Cannalean Biotechs Ltd. was established in partnership with 'Mor Research Applications'
the technology transfer unit of the largest HMO in Israel - ‘CLALIT’ Health Services (CHS).

Cannalean Biotechs Ltd.

14-18 Baruch Hirsh,
Bnei Brak, 5120206, Israel

Tel: (972) 3 617 6644
Fax: (972) 3 617 6647
E-mail: mail@cannaleanbio.com